Steven Romano
Fortune : - $ au 31/08/2026
Fortune : - $ au 31/08/2026
Steven Joseph Romano is currently Chairman at National Pharmaceutical Council since 2021, Director at Evolution Research Group LLC, Independent Director at Dianthus Therapeutics, Inc. since 2024, and Chief Research & Development, Executive VP at Silence Therapeutics Plc since 2019.
Formerly, Dr. Romano was Senior VP & Head-Global Medicines Development at Pfizer Inc. from 1999 to 2015, Chief Scientific Officer & Executive VP at Keenova Therapeutics Plc from 2015 to 2022, Chief Scientific Officer & Executive VP at Mallinckrodt Pharmaceuticals Ltd. from 2015 to 2022, and President of the International Society For CNS Clinical Trials & Methodology.
Education includes undergraduate studies at Washington University in St. Louis and a doctorate from the University of Missouri School of Medicine.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 21/05/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| SILENCE THERAPEUTICS PLC | Directeur Technique/Scientifique/R&D | 01/04/2023 |
| DIANTHUS THERAPEUTICS, INC. | Directeur/Membre du Conseil | 16/09/2024 |
National Pharmaceutical Council
National Pharmaceutical Council Miscellaneous Commercial ServicesCommercial Services Operates as a not for profit organization which specializes in research development, information dissemination, education and communication of information to patients | Président | 04/11/2021 |
Evolution Research Group LLC
Evolution Research Group LLC Miscellaneous Commercial ServicesCommercial Services Provides clinical research services | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
| MALLINCKRODT PLC | Directeur Technique/Scientifique/R&D | 31/12/2022 |
Mallinckrodt Pharmaceuticals Ltd.
Mallinckrodt Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur Technique/Scientifique/R&D | 01/12/2022 |
| PFIZER INC. | Corporate Officer/Principal | 01/05/2015 |
International Society For Cns Clinical Trials & Methodology | President | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 10 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Washington University in St. Louis
Washington University in St. Louis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Keenova Therapeutics Plc
Keenova Therapeutics Plc BiotechnologyHealth Technology Develops therapeutics for rheumatology, ophthalmology, nephrology, neurology, pulmonology, orthopedics, urology and neonatal respiratory problems | Health Technology |
Silence Therapeutics Plc
Silence Therapeutics Plc Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of novel pharmaceutical products | Commercial Services |
National Pharmaceutical Council
National Pharmaceutical Council Miscellaneous Commercial ServicesCommercial Services Operates as a not for profit organization which specializes in research development, information dissemination, education and communication of information to patients | Commercial Services |
University of Missouri School of Medicine
University of Missouri School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Evolution Research Group LLC
Evolution Research Group LLC Miscellaneous Commercial ServicesCommercial Services Provides clinical research services | Commercial Services |
Mallinckrodt Pharmaceuticals Ltd.
Mallinckrodt Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
International Society For Cns Clinical Trials & Methodology | |
Dianthus Therapeutics, Inc.
Dianthus Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for patients with autoimmune and inflammatory diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national